{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Auto+Immune+Disease&page=2", "query": { "condition": "Auto Immune Disease", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Auto+Immune+Disease&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-11T07:35:11.120Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04141891", "title": "Advancing Understanding of Transportation Options", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Retinopathy", "Macular Degeneration", "Glaucoma", "Retinitis Pigmentosa", "Vision Disorders", "Acute Coronary Syndrome", "Implantable Defibrillator User", "Congestive Heart Failure", "Hypertrophic Obstructive Cardiomyopathy", "Orthostatic Hypotension", "Syncope", "Presyncope", "Narcolepsy", "Dementia", "Multiple Sclerosis", "Parkinson Disease", "Brain Injuries", "Spinal Cord Injuries", "Stroke", "Vertigo", "Dizziness", "Seizures", "Substance Use", "Insulin Dependent Diabetes Mellitus", "Arthritis", "Foot--Abnormalities", "Chronic Obstructive Pulmonary Disease", "Obstructive Sleep Apnea", "End Stage Renal Disease", "Sleep Apnea", "Insomnia", "Restless Legs Syndrome" ], "interventions": [ { "name": "Driving Decision Aid", "type": "BEHAVIORAL" }, { "name": "Older Drivers Website", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 529, "start_date": "2019-12-12", "completion_date": "2023-12-21", "has_results": true, "last_update_posted_date": "2025-02-21", "last_synced_at": "2026-06-11T07:35:11.120Z", "location_count": 3, "location_summary": "La Jolla, California • Aurora, Colorado • Indianapolis, Indiana", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04141891" }, { "nct_id": "NCT04146051", "title": "Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myasthenia Gravis, Generalized" ], "interventions": [ { "name": "Descartes-08", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cartesian Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2019-12-04", "completion_date": "2026-03-31", "has_results": false, "last_update_posted_date": "2025-05-28", "last_synced_at": "2026-06-11T07:35:11.120Z", "location_count": 14, "location_summary": "Carlsbad, California • Irvine, California • Aurora, Colorado + 11 more", "locations": [ { "city": "Carlsbad", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04146051" }, { "nct_id": "NCT04052022", "title": "Paradoxical Tuberculosis Reactions in Patients Without HIV Infection", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Tuberculosis" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 140, "start_date": "2019-12-20", "completion_date": "2029-04-30", "has_results": false, "last_update_posted_date": "2026-04-30", "last_synced_at": "2026-06-11T07:35:11.120Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04052022" }, { "nct_id": "NCT02852967", "title": "A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Plaque Psoriasis" ], "interventions": [ { "name": "Belumosudil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kadmon Corporation, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 110, "start_date": "2016-09-14", "completion_date": "2019-02-13", "has_results": true, "last_update_posted_date": "2022-03-16", "last_synced_at": "2026-06-11T07:35:11.120Z", "location_count": 14, "location_summary": "Phoenix, Arizona • Irvine, California • Los Angeles, California + 11 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Ocala", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02852967" }, { "nct_id": "NCT01009281", "title": "An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease", "Inflammatory Bowel Disease" ], "interventions": [ { "name": "AIN457", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 7, "start_date": "2009-10-30", "completion_date": "2010-08-19", "has_results": true, "last_update_posted_date": "2021-07-12", "last_synced_at": "2026-06-11T07:35:11.120Z", "location_count": 5, "location_summary": "Bristol, Connecticut • Great Neck, New York • New York, New York + 2 more", "locations": [ { "city": "Bristol", "state": "Connecticut" }, { "city": "Great Neck", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01009281" }, { "nct_id": "NCT01468311", "title": "Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hodgkin Disease", "Hodgkin Lymphoma" ], "interventions": [ { "name": "Auto stem cell transplant", "type": "PROCEDURE" }, { "name": "BEAM", "type": "DRUG" }, { "name": "111In-daclizumab", "type": "RADIATION" }, { "name": "90Y-daclizumab", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "DRUG", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 6, "start_date": "2011-10-11", "completion_date": "2020-10-22", "has_results": true, "last_update_posted_date": "2021-10-06", "last_synced_at": "2026-06-11T07:35:11.120Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01468311" }, { "nct_id": "NCT01993732", "title": "Ovarian Tissue Cryopreservation in Females Undergoing Procedures That Will Potentially Lead To Loss of Ovarian Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer", "Effects of Chemotherapy", "Unspecified Complication of Bone Marrow Transplant", "Auto Immune Disease" ], "interventions": [ { "name": "Retrieval and Cryopreservation", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": null, "sex": "FEMALE", "summary": "3 Years and older · Female only" }, "enrollment_count": 15, "start_date": "2013-08-06", "completion_date": "2018-06-28", "has_results": false, "last_update_posted_date": "2019-08-14", "last_synced_at": "2026-06-11T07:35:11.120Z", "location_count": 2, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01993732" }, { "nct_id": "NCT00879658", "title": "Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Relapsing-remitting Multiple Sclerosis" ], "interventions": [ { "name": "BAF312", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 297, "start_date": "2009-03-30", "completion_date": "2011-05-04", "has_results": true, "last_update_posted_date": "2020-01-13", "last_synced_at": "2026-06-11T07:35:11.120Z", "location_count": 16, "location_summary": "Cullman, Alabama • San Francisco, California • Centennial, Colorado + 13 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Pompano Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00879658" }, { "nct_id": "NCT02296424", "title": "ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Systemic Juvenile Idiopathic Arthritis (SJIA)" ], "interventions": [ { "name": "ACZ885 150 mg (Canakinumab)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "2 Years to 20 Years" }, "enrollment_count": 182, "start_date": "2014-11-17", "completion_date": "2017-09-25", "has_results": true, "last_update_posted_date": "2019-07-09", "last_synced_at": "2026-06-11T07:35:11.120Z", "location_count": 2, "location_summary": "Los Angeles, California • Columbus, Ohio", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02296424" }, { "nct_id": "NCT01697254", "title": "The CARRA Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Juvenile Idiopathic Arthritis", "Systemic Lupus Erythematosus", "Mixed Connective Tissue Disease", "Juvenile Ankylosing Spondylitis", "Juvenile Dermatomyositis", "Localized Scleroderma", "Systemic Sclerosis", "Vasculitis", "Sarcoid", "Fibromyalgia, Primary", "Auto-inflammatory Disease", "Idiopathic Uveitis Idiopathic" ], "interventions": [], "intervention_types": [], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 9587, "start_date": "2009-08", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2015-11-17", "last_synced_at": "2026-06-11T07:35:11.120Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01697254" } ] }